Search
for
Sort by
Research 61–90 of 552
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Medical management of benign prostatic hyperplasia
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- The pharmacological treatment of alopecia areata
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- Treatment of actinic cheilitis with ingenol mebutate gel: Experience in four patients
- Study of QuantiFERON’S conversion/reversal phenomena in patients with psoriasis during biological treatment
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- FDA approves label addition for PDE-5 inhibitor
- Caffeine and Its Role in Regulation the Androgenetic Alopecia.
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- Anti‐hair loss effect of a shampoo containing caffeine and adenosine
- A COMPREHENSIVE REVIEW ON PHARMACOLOGICAL POTENTIALS OF CAFFEINE
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
- ENZYMES
- Lower Urinary Tract Symptoms in Men
- From bench to babies – drug development for male subfertility
- Secreted Carbonic Anhydrase Isoenzyme VI
- When two plus two must not equal four
- Novel effect of sildenafil on hair growth